We aim for sustainable performance over time to benefit patients, employees, shareholders and society. Solid financial results and maintaining the trust of society underpin our ability to create value.
First quarter results 2025
April 29, 2025
Basel, Switzerland
Watch the webcast
14:00 CEST | 13:00 BST | 08:00 EDT
Investors event calendar
View recent presentations and learn more about upcoming events
Environmental, Social and Governance (ESG)
Novartis aims to hold itself to the highest standards of sustainability and ethical business practices. We take bold steps to increase access to medicines, tackle complex global health challenges, and do our part as a responsible corporate citizen.
ESG updates: February 2025 (PDF 1.0 MB) | October 2024 (PDF 0.6 MB) | July 2024 (PDF 0.9 MB) | April 2024 (PDF 1.0 MB)
Latest updates: Impact & Sustainability (PDF 1.9 MB) | Impact & Health Equity (PDF 9.9 MB) | Novartis Enterprise Risk Management (PDF 0.2 MB)
We have created a set of environmental, social and governance indices to signpost where our key disclosures can be found across our publications and channels. Novartis aims to report comprehensively and transparently for all stakeholders concerned with ESG topics.
Reporting and transparency hub
Read our regulatory filings; policies, codes and guidelines that govern our activities; and environmental, social and governance (ESG) disclosures.
Stocks